Published in
Springer, Cancer Chemotherapy and Pharmacology, 1(77), p. 35-41, 2015
DOI: 10.1007/s00280-015-2928-z
Links
Tools
Phase I study assessing the feasibility of the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic ductal adenocarcinoma
Journal article published in 2015 by
Hiroaki Yanagimoto,
Sohei Satoi,
Masayuki Sho,
Takahiro Akahori,
Tomohisa Yamamoto 
,
Satoshi Hirooka,
So Yamaki,
Masaya Kotsuka,
Hironori Ryota,
Shoichi Kinoshita,
Satoshi Nishiwada,
Minako Nagai,
Naoya Ikeda,
Koji Tsuta,
Yoshiyuki Nakajima
and other authors.
,
Satoshi Hirooka,
So Yamaki,
Masaya Kotsuka,
Hironori Ryota,
Shoichi Kinoshita,
Satoshi Nishiwada,
Minako Nagai,
Naoya Ikeda,
Koji Tsuta,
Yoshiyuki Nakajima
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 